个人简介
2011/9 - 2014/7,中国药科大学,药物代谢动力学,博士
2012/3 - 2013/12,北京大学,药剂学,联合培养博士
2008/9 - 2011/7,中国药科大学,药剂学,硕士
2004/9 - 2008/7,中国药科大学,中药学,学士
研究领域
口服固体制剂、纳米微粒给药系统、纳米制剂同生物体相互作用
近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
1、Qin Chao, He Bing, Dai Wenbing, Lin Zhiqiang, Zhang Hua, Wang Xueqing, Wang Jiancheng, Zhang Xuan, Wang Guangji*, Yin Lifang*, Zhang Qiang*. The impact of a chlorotoxin modified liposome system on receptor MMP-2 and the receptor-associated protein ClC-3. Biomaterials. 2014 Jul;35(22):5908-20.
2、Qin Chao, He Bing, Dai Wenbing, Zhang Hua, Wang Xueqing, Wang Jiancheng, Zhang Xuan, Wang Guangji*, Yin Lifang*, Zhang Qiang*. Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes. Mol Pharm. 2014 Oct 6;11(10):3233-41.
3、Qin Chao1,He Wei1, Zhu Chunli, Wu Mengmeng, Jin Zhu, Zhang Qiang, Wang Guangji, Yin Lifang*. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet. Int J Pharm. 2014 May 15;466(1-2):276-85.
4、Yin Lifang1, Qin Chao1, Chen Kaisheng, Zhu Chunli, Cao Hui, Zhou Jianping, He Wei*, Zhang Qiang*. Gastro-floating tablets of cephalexin: preparation and in vitro/in vivo evaluation. Int J Pharm. 2013 Aug 16; 452 (1-2): 241-248.